HIV/AIDS

Through our Digital Healthcare m-Kliniki app we choose to make a difference about HIV & AIDS; –

  1. HIV testing


Referrals through our app’s HIV/AIDS platform of Health specialists and facilities enabling Young People learn about HIV Testing and do 24 hours system follow up on whether they were served and enrolled under Care program

1.PrEP; through our health specialists, we encourage them and guide them on wherethey can access PrEP

  • Pre-exposure prophylaxis (PrEP) is a daily course of antiretroviral drugs (ARVs) taken by HIV-negative people to protect themselves from infection.
  • Evidence shows that, when taken consistently and correctly, PrEP reduces the chances of HIV infection to near-zero.
  • PrEP is cost effective, and there is growing demand for it from people at higher risk of HIV infection, but the scale and coverage currently remains limited.
  • PrEP does not protect against other STIs so needs to be delivered as part of a comprehensive package of HIV/STI prevention services.
  • PrEP’s effectiveness decreases rapidly if not taken regularly as prescribed, so addressing the barriers preventing adherence is key to success.

Package of services

Because PrEP is only fully effective when it is adhered to exactly as prescribed – and also does not protect against other STIs – it needs to be delivered as part of a comprehensive package of HIV/STI prevention services based on an individual’s circumstances. These might include condoms and lubricant, safer sex counselling, frequent STI check-ups and treatment and regular HIV testing.

  • Essential Care & Treatment Package for PLHIV (People Living with HIV); –
  • All patients should have a confirmed and documented HIV diagnosis in their file
  • All HIV infected adults should be evaluated clinically in the CCC at least every month till stable, then every three (3) months; follow-up should be as individualized as possible
  • HTS should be provided to partner(s) and family members of the index patient
  • Adherence assessment and counselling, psychosocial support and PHDP services should be provided to all PLHIV at every visit
  • All PLHIV should be provided with long-term HIV care and follow up including community linkages
  • All patients should undergo nutritional assessment and counselling at every visit, and if needed, nutritional services
  • All PLHIV should receive STI screening at every visit
  • All HIV infected women should receive pregnancy screening at every visit
  • Cervical cancer screening should be integrated into routine care for all sexually active women
  • All HIV infected women of reproductive age should receive dual contraception at every visit
  • All patients should be screened for TB at enrolment and at every visit
  • All patients should be screened for IPT and isoniazid provided to eligible patients as per national guidelines
  • Co-trimoxazole prophylaxis therapy should be provided to all patients regardless of CD4 counts
  • Anti-HBV, pneumococcal polysaccharide and influenza vaccines should be offered to all eligible patients where available
  • All patients must be triaged at every visit the and trends in BMI and blood pressure monitored
  • Clinical assessment must be conducted for all patients at enrolment and at every visit
  • Basic laboratory tests where available, should be conducted for all patients at baseline, at ART initiation, and thereafter as directed by the patient’s symptoms or ART regimen
  • Cryptococcal antigen test should be conducted for all patients with CD4
  • CD4 tests should be done for all patients within two (2) weeks of enrolment and for pre-ART patients, every six (6) months thereafter
  • Patients who are eligible for ART should be initiated within one (1) month of enrolment
  • All patients on chronic HAART should be monitored for antiretroviral treatment failure using clinical criteria at every visit
  • All PLHIV on chronic HAART should be monitored for ART failure using virologic criteria after six (6) months on ART, after one (1) year, and annually thereafter
  • All patients should be monitored for adverse events at every visit including six (6) monthly creatinine test for patients on TDF
  • All HIV infected patients should be managed promptly for all opportunistic infections